CONMED Corporation Announces Annual Meeting of Stockholders

Rhea-AI Summary

CONMED Corporation (NYSE: CNMD) announced that its Annual Meeting of Stockholders will take place on May 24, 2023, at 1:30 p.m. ET at its headquarters in Largo, FL, and virtually. Shareholders of record by March 28, 2023 can vote. Further details will be in a definitive proxy statement filed with the Securities and Exchange Commission on April 11, 2023, available on CONMED's website.

CONMED specializes in surgical devices for minimally invasive procedures across various medical fields. The company emphasizes its commitment to addressing risks and uncertainties, notably those arising from the ongoing COVID-19 pandemic.

Positive

• Scheduled Annual Meeting of Stockholders indicating corporate governance and shareholder engagement.

Negative

• Potential risks from COVID-19 affecting surgery volumes and overall financial performance.

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 24, 2023, at 1:30 p.m. ET at its corporate headquarters at 11311 Concept Boulevard, Largo FL and through the internet virtually. Shareholders of record at the close of business on March 28, 2023 shall be entitled to vote at the 2023 Annual Meeting.

Information about the meeting webcast and instructions for how stockholders can attend or otherwise participate in the Annual Meeting will be included in the definitive proxy statement expected to be filed with the Securities and Exchange Commission on April 11, 2023 and available on the “Investors” section of CONMED’s web site at www.conmed.com on that date.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government and other responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2022 and listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230322005594/en/

CONMED Corporation

Todd W. Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

What date is the Annual Meeting for CONMED Corporation?

The Annual Meeting of Stockholders for CONMED Corporation is scheduled for May 24, 2023.

What is the significance of the stockholder record date for CNMD?

Shareholders of record as of March 28, 2023, are entitled to vote at the Annual Meeting.

Where will the CONMED Annual Meeting be held?

The Annual Meeting will be held at CONMED's headquarters in Largo, FL, and virtually.

What kind of company is CONMED Corporation?

CONMED Corporation is a medical technology company that provides surgical devices for minimally invasive procedures.

When will the proxy statement for CNMD's Annual Meeting be available?

The definitive proxy statement is expected to be filed with the SEC on April 11, 2023.